Shigella: Difference between revisions

From IDWiki
Shigella
m (Text replacement - "[[Cellular shape::" to "[[Shape::")
No edit summary
Line 1: Line 1:
 
==Background==
 
==Background==
   
*[[Stain::Gram-negative]] [[Shape::bacillus]] that is closely related to [[Escherichia coli]]
+
*[[Stain::Gram-negative]] [[Shape::bacillus]] within the family [[Family::Enterobacteriaceae]] and order [[Order::Enterobacterales]]
  +
**Most closely related to [[Escherichia coli]]
  +
*Species include [[Shigella dysenteriae]], [[Shigella sonnei]], [[Shigella flexneri]], and [[Shigella boydii]]
  +
**At least 40 serotypes
  +
*Strains that encode Shiga toxin include [[Shigella dysenteriae]] serotype 1 (most common), [[Shigella flexneri]] type 2a, [[Shigella dysenteriae]] type 4, and [[Shigella sonnei]]
 
*Automated methods frequently misidentify as [[Escherichia coli]], so needs phenotypic testing with serology
 
*Automated methods frequently misidentify as [[Escherichia coli]], so needs phenotypic testing with serology
*Needs azithromycin susceptibility to be requested specifically, if it is resistant to others
+
*Needs [[azithromycin]] susceptibility to be requested specifically, if it is resistant to others
 
**However, there are no standardized breakpoints, so you have to use the epidemiologic cutoff values
 
**However, there are no standardized breakpoints, so you have to use the epidemiologic cutoff values
   
== Clinical Manifestations ==
+
==Clinical Manifestations==
   
  +
* Most commonly causes self-limited diarrheal illness with watery or loose stools
=== Post-Infectious Complications ===
 
  +
* Disease may be more severe, including high fever, abdominal cramps, abdominal tenderness, tenesmus, mucoid stools, and [[hematochezia]]
  +
* Complications of severe disease include [[bacteremia]], [[pseudomembranous colitis]], [[toxic megacolon]], [[intestinal perforation]], [[hemolysis]], and [[hemolytic-uremic syndrome]]
  +
** Bacteremia more common in neonates and patients with malnutrition
  +
* Serotype 1 is more likely to cause severe illness
   
 
===Post-Infectious Complications===
* [[Hemolytic-uremic syndrome]]
 
  +
* [[Reactive arthritis]]
 
 
*[[Hemolytic-uremic syndrome]]
* [[Seizures]]
 
 
*[[Reactive arthritis]]
 
*[[Seizures]]
  +
  +
== Diagnosis ==
  +
  +
* Molecular testing with PCR of stool is the most common method of diagnosing diarrheal illness
  +
* Culture of stool or rectal swab
  +
** Mass spectrometry cannot reliably differentiate from [[Escherichia coli]], so needs biochemical identification
  +
  +
== Management ==
  +
  +
* Supportive care and oral rehydration
  +
* Avoid antidiarrheal or antimotility agents, which can prolong the clinical course and increase risk of severe disease
  +
* If severe disease or immunocompromised, should be treated empirically with antimicrobials
  +
** Ideally should be directed by susceptibility data
  +
** [[Azithromycin]] for 3 days or [[ceftriaxone]] for 2 to 5 days are good empiric options, though resistance is increasing
  +
** Other options include [[ciprofloxacin]] for 3 days, [[ampicillin]] for 5 days, or [[trimethoprim-sulfamethoxazole]] for 5 days
  +
*** Avoid [[fluoroquinolones]] if MIC ≥0.12 μg/mL
  +
*** Avoid [[amoxicillin]], which may not be well-absorbed
 
{{DISPLAYTITLE:''Shigella'' species}}
 
{{DISPLAYTITLE:''Shigella'' species}}
 
[[Category:Gram-negative bacilli]]
 
[[Category:Gram-negative bacilli]]
  +
[[Category:Gastrointestinal infections]]

Revision as of 12:32, 3 November 2020

Background

Clinical Manifestations

Post-Infectious Complications

Diagnosis

  • Molecular testing with PCR of stool is the most common method of diagnosing diarrheal illness
  • Culture of stool or rectal swab
    • Mass spectrometry cannot reliably differentiate from Escherichia coli, so needs biochemical identification

Management

  • Supportive care and oral rehydration
  • Avoid antidiarrheal or antimotility agents, which can prolong the clinical course and increase risk of severe disease
  • If severe disease or immunocompromised, should be treated empirically with antimicrobials